Legend Biotech Corp insider trading
Every open-market purchase and sale by Legend Biotech Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $0 0 trades by 0 insiders Insider sales, 5 years $566,754 5 trades by 4 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Legend Biotech Corp’s insiders pay?
From March 27, 2026 to October 1, 2026, 4 insiders reported 0 open-market purchases and 5 sales not made under a pre-set plan in Legend Biotech Corp.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Huang Ying | Chief Executive Officer | 0 | — | — | 2 | — | June 29, 2026 |
| Casey Patrick John | Director | 0 | — | — | 1 | — | July 2, 2026 |
| Sanders Corazon (corsee) D. | Director | 0 | — | — | 1 | — | October 1, 2026 |
| Santos Carlos E | Chief Financial Officer | 0 | — | — | 1 | — | September 23, 2026 |